SCHEMBL19403922

SCHEMBL19403922

O=C(OC1CCCC(c2ccccc2Cl)C1=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ CHRM2 P08172 1/20 0.45
▸ CHRM4 P08173 1/20 0.45
▸ CHRM1 P11229 1/20 0.45
▸ CHRM3 P20309 1/20 0.45
▸ PTPN2 P17706 1/20 0.44
▸ PTPN1 P18031 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ POLB P06746 2/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.40
▸ PKM P14618 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23352415 1.00 MAPT (0.45) MAPTKDM4ELMNACHRM2CHRM4
SCHEMBL26340003 0.84 KDM4E (0.37) KDM4EPOLBMEN1KMT2AALDH1A1
SCHEMBL26340042 0.81 ALDH1A1 (0.42) MAPTKDM4EPOLBALDH1A1RAB9A
SCHEMBL7633022 0.73 MEN1 (0.60) MAPTKDM4ELMNACHRM2CHRM4
SCHEMBL18460807 0.71 PTPN2 (0.70) MAPTKDM4ELMNACHRM2CHRM4
SCHEMBL16398689 0.71 POLB (0.61) MAPTCHRM2CHRM4CHRM1CHRM3
SCHEMBL25771258 0.70 TP53 (0.39) KDM4ESMN1; SMN2ALDH1A1
SCHEMBL26340378 0.69 ALDH1A1 (0.42) MAPTKDM4ESMN1; SMN2KMT2AALDH1A1
SCHEMBL27400395 0.69 PTPN2 (0.70) MAPTKDM4ELMNACHRM2CHRM4
SCHEMBL16398974 0.69 PTPN2 (0.51) MAPTKDM4ECHRM2CHRM4CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017165878-A1 CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2017-09-28 — — WO disclosed
Send feedback